Stocks from pharmaceutical companies and healthcare spaces dominated analysts' choices for Thursday's trading session.

Assistant Editor, Hannah Blake, picks this series back up, starting here with the history of GlaxoSmithKline. GlaxoSmithKline (GSK) is a science-led global healthcare company, which headquarters ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

With the stock's current price at Rs 2819.60, GlaxoSmithKline Pharmaceuticals is navigating through market dynamics, ...

With a neutral sentiment as of May 8, 2025, according to Moneycontrol analysis, GlaxoSmithKline Pharmaceuticals demonstrates ...

Todays focus will be on GSK Pharma shares in light of the companys announced topline growth and profitability for the full ...

GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) reported a 9% revenue growth, predominantly led by volume growth. The company achieved a 30% growth in EBITDA, with margins improving from 26% to ...

1 Day BIOC 0.42% DJIA -0.64% Russell 2K 0.00% Health Care/Life Sciences -1.52% ...

The company is working closely with the contract manufacturing facility for resumption of operations. Shares of ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2827.05. The stock has experienced fluctuations ...